| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/10/2009 | EP2066340A2 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 06/10/2009 | EP2066339A2 Compositions and methods of enhancing immune responses |
| 06/10/2009 | EP2066335A1 Cytokine signaling |
| 06/10/2009 | EP2066332A1 Flu vaccine admixture of mannan and flu antigen |
| 06/10/2009 | EP2066320A1 Methods and compositions for treating lymphoma and myeloma |
| 06/10/2009 | EP2066174A2 Compositions containing alpha-1-antitrypsin and methods for use |
| 06/10/2009 | EP1579870B1 Vaccines comprising polynucleotides |
| 06/10/2009 | EP1362109B1 Recombinant oligomeric protein complexes with enhanced immunogenic potential |
| 06/10/2009 | EP1327147B1 Neurotransmission disorders |
| 06/10/2009 | EP1242115B1 Chemically-programmable immunity |
| 06/10/2009 | EP0831892B1 Multimeric, recombinant urease vaccine |
| 06/10/2009 | CN101454451A C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 06/10/2009 | CN101454025A 抗体纯化 Antibody Purification |
| 06/10/2009 | CN101454024A Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| 06/10/2009 | CN101454023A Defective interfering virus |
| 06/10/2009 | CN101454022A Pseudoinfectious flavivirus and uses thereof |
| 06/10/2009 | CN101454021A Vaccine against rickettsia-like organisms |
| 06/10/2009 | CN101454020A Vaccination of young animals against lawsonia intracellularis infections |
| 06/10/2009 | CN101450210A Medicine for treating anaphylactic disease and preparation method thereof |
| 06/10/2009 | CN101450209A Transdermal immune influenza multivalent vaccine and preparation method thereof |
| 06/10/2009 | CN101450208A Nasal-spraying immune influenza multivalent vaccine and preparation method thereof |
| 06/10/2009 | CN101450207A Human influenza-poultry influenza combined vaccine and preparation method thereof |
| 06/10/2009 | CN101450206A Production method of Escherichia coli K88, K99, 987P cilia subunit oil-emulsion vaccine |
| 06/10/2009 | CN100497629C Live vaccine for treating anaphylaxis |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497610C Polypeptides encoded by human lipase-like gene and composition, and methods of utilizing same |
| 06/10/2009 | CN100497604C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 06/10/2009 | CN100497601C Human myeloma cell line |
| 06/10/2009 | CN100497393C Method of detecting precursor with a monoclonal antibody binding to the amino acids 41-46 of brain natriuretic peptide |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497391C Humanized gene engineering antibody resisting hepatitis E virus |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497385C Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome |
| 06/10/2009 | CN100497379C Protein complex serving as vehicle for orally administerable medicaments |
| 06/10/2009 | CN100496605C Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof |
| 06/09/2009 | US7544792 Compositions and methods for detection of hepatitis A virus nucleic acid |
| 06/09/2009 | US7544791 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 06/09/2009 | US7544790 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis |
| 06/09/2009 | US7544783 Active constituent in antiallergic medicine; block the IgE acceptor; specifically bind to a native IgG inhibitory receptor containing immunoreceptor tyrosine-based inhibitory motif, thereby inhibiting the IgE-driven mediator release from mast cells and basophils |
| 06/09/2009 | US7544782 Tumour necrosis factor binding ligands |
| 06/09/2009 | US7544779 cysteine mutant proteins that bind to their cognate receptor or exhibit antiviral activity; polypeptides; fusion proteins |
| 06/09/2009 | US7544777 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/09/2009 | US7544771 Identifying patients with or at risk of developing Alzheimer's Disease and other neurodegenerative diseases; purifying a biological sample and determining amount of protein biomarker |
| 06/09/2009 | US7544669 Polynucleotide therapy |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544510 Stem cells of the islets of Langerhans and their use in treating diabetes mellitus |
| 06/09/2009 | US7544491 TANGO 240 nucleic acids and uses thereof |
| 06/09/2009 | US7544487 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/09/2009 | US7544467 Method for the identification of compounds capable of activating latent human immunodeficiency virus (HIV) |
| 06/09/2009 | US7544365 TRPV1+ sensory neurons control of β-cells stress and islet inflammation in diabetes |
| 06/09/2009 | US7544363 Exhibit probiotic activity in aerobic conditions; does not contribute to the production of future generation of antibiotic resistant pathogens |
| 06/09/2009 | US7544362 N protein mutants of porcine reproductive and respiratory syndrome virus |
| 06/09/2009 | US7544361 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration |
| 06/09/2009 | US7544360 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | US7544358 Bacterial sepsis, hemorrhagic shock, toxic inhalation, and bleomycin and other drug-induced lung injury; fibronectin and tenascin receptor antagonist; cancer |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | US7544327 A stimulating source (laser), a transducer having cantilever beam(s) upon which surface are immobilized antibodies against tartrate-resistant phosphatase, a signal detecting unit, and a signal processing unit for retrieving/analyzing signals; high-speed test; monotoring/preventing osteoporosis |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2317443C Agent for treating allergic or hypersensitivity condition |
| 06/09/2009 | CA2199408C Herpes simplex virus glycoprotein d variants |
| 06/04/2009 | WO2009070700A1 Recombinant bcg tuberculosis vaccine for eliciting immune responses to mycobacterium tuberculosis |
| 06/04/2009 | WO2009070642A1 Protein formulation |
| 06/04/2009 | WO2009070328A1 Modulators of the epidermal growth factor receptor (egfr) pathway for use in the treatment or prevention of substance abuse |
| 06/04/2009 | WO2009070302A1 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| 06/04/2009 | WO2009070294A2 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 06/04/2009 | WO2009070243A2 Wise binding antibodies and epitopes |
| 06/04/2009 | WO2009070118A1 Novel wheat allergens |
| 06/04/2009 | WO2009069983A2 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 06/04/2009 | WO2009069917A1 Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection |
| 06/04/2009 | WO2009069916A1 Pharmaceutical formulation comprising hepatitis b virus neutralizing human antibody |
| 06/04/2009 | WO2009069448A1 Adjuvant for japanese b encephalitis vaccine, and japanese b encephalitis vaccine |
| 06/04/2009 | WO2009069447A1 Adjuvant for influenza vaccine, and influenza vaccine |
| 06/04/2009 | WO2009069355A1 Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell |
| 06/04/2009 | WO2009069302A1 Stat3 epitope peptides |
| 06/04/2009 | WO2009069130A2 New adjuvant |
| 06/04/2009 | WO2009068992A1 Vaccination with multiple clades of h5 influenza a virus |
| 06/04/2009 | WO2009068870A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/04/2009 | WO2009068753A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 06/04/2009 | WO2009068649A2 Antigen-binding constructs |
| 06/04/2009 | WO2009068545A1 Carrier particle for a microorganism or subunit thereof, pharmaceutical composition comprising such particles, method for preparation of this composition and its use in the treatment of animals |
| 06/04/2009 | WO2009068335A1 Human monoclonal nicotine specific antibodies |
| 06/04/2009 | WO2009068204A1 Anti-mesothelin antibodies and uses therefor |
| 06/04/2009 | WO2009067820A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | WO2009067811A1 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis |
| 06/04/2009 | WO2009067800A1 Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof |
| 06/04/2009 | WO2009067755A1 Therapeutic targets and medicaments involving p230/golgin-245 |
| 06/04/2009 | WO2009052439A3 Immunotherapy regimes dependent on apoe status |
| 06/04/2009 | WO2009052081A3 Antibodies that bind il-4 and/or il-13 and their uses |
| 06/04/2009 | WO2009051555A3 Modified mhc class i binding peptides |
| 06/04/2009 | WO2009051265A3 Stabilisation of antibodies on hazardous subtance-removing material and method of removing hazardous substances |
| 06/04/2009 | WO2009045308A3 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression |
| 06/04/2009 | WO2009040674A3 A public and immunogenic cd4+ t cell epitope of the hiv tat protein and its applications |
| 06/04/2009 | WO2009037439A3 Methods of switching the phenotype of t cells by transgenic lineage factor foxp3 |
| 06/04/2009 | WO2009034315A3 Vaccine |
| 06/04/2009 | WO2009026397A3 Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods |
| 06/04/2009 | WO2009024534A3 Japanese encephalitis virus (jev) and tick-borne encephalitis virus (tbev) peptides stimulating human t cell responses |
| 06/04/2009 | WO2009022216A3 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |